Can Virtual Reality Technology Improve the Patient Experience in Oocyte Retrieval?

Peter Humaidan1 site in 1 country82 target enrollmentMarch 13, 2023

ConditionsInfertility, Female

Overview

Phase: N/A
Intervention: Not specified
Conditions: Infertility, Female
Sponsor: Peter Humaidan
Enrollment: 82
Locations: 1
Primary Endpoint: Questionnaires regarding impact on patient experience
Status: Recruiting
Last Updated: 3 years ago

Overview Investigators Eligibility Criteria Outcomes Sites Similar Trials

Overview

Brief Summary

A non-pharmacological, non-blinded, randomized cohort study that will investigate the effect of Virtual Reality technology on the patient experience during oocyte retrieval.

The primary objective of the trial is to investigate the impact of Virtual Reality technology on the patient experience

Registry

clinicaltrials.gov

Start Date

March 13, 2023

End Date

March 13, 2024

Last Updated

3 years ago

Study Type

Interventional

Study Design

Parallel

Sex

Female

Investigators

Sponsor

Peter Humaidan

Responsible Party

Sponsor Investigator

Principal Investigator

Peter Humaidan

Professor, Consultant

Regionshospitalet Viborg, Skive

Eligibility Criteria

Inclusion Criteria

•Women undergoing oocyte retrieval
•Understanding and speaking Danish

Exclusion Criteria

•Previous participation in the trial
•Acupuncture as pain relief during oocyte retrieval

Outcomes

Primary Outcomes

Questionnaires regarding impact on patient experience

Time Frame: 30-60 minutes

The impact of Virtual Reality technology on the patient experience during oocyte retrieval through questionnaires. A visual analog scale (VAS) from 1-10 will be used for this measurement.